STAAR SURGICAL CO — Director's Dealing 2021

Mar 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-03-01

Reporting Person: Mason Caren L (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-01	Common Stock	M	45000	$7.76	Acquired	89013	Direct
2021-03-01	Common Stock	S	45000	$104.76	Disposed	44013	Direct
2021-03-02	Common Stock	M	45000	$7.76	Acquired	89013	Direct
2021-03-02	Common Stock	S	45000	$103.53	Disposed	44013	Direct
2021-03-03	Common Stock	M	45000	$7.76	Acquired	89013	Direct
2021-03-03	Common Stock	S	45000	$98.32	Disposed	44013	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-01	Common Stock Options	$7.76	M	45000	Disposed	2025-03-02	Common Stock (45000)	Direct
2021-03-02	Common Stock Options	$7.76	M	45000	Disposed	2025-03-02	Common Stock (45000)	Direct
2021-03-03	Common Stock Options	$7.76	M	45000	Disposed	2025-03-02	Common Stock (45000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.40 to $106.64.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.83 to $106.91.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.09 to $103.20.